David Brower

Company: Accent Therapeutics

Job title: Chief Business Officer

Seminars:

Panel Discussion: Discussing Investment in RNA-Targeting Therapeutics to Accelerate Advancement of Small Molecule Therapies for Patients in Need 2:00 pm

What motivation do venture capitalists need to invest in RNA targeting small molecule therapeutics? What do venture capitalists view as critical points of investment both in preclinical and early clinical development? What do investors look for in investable ideas and approaches within the RNA-targeting field?Read more

day: Day Two